Kewaunee Scientific Corporation
corporate_fare Company Profile
Kewaunee Scientific Corporation (NASDAQ:KEQU) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for KEQU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 9/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for KEQU spans 8-K, DEF 14A, 4, 10-K.
Recent high-impact activity:
- Kewaunee to Buy Nycom for $55M Base Price, Adding $20M Seller Note and $5M Stock
- Kewaunee Scientific Signs Deal to Acquire Nycom
- Kewaunee Scientific Q1 Sales Fall 6.7% as Life Sciences Demand Weakens
- Executive Pay Disconnect Revealed Amidst Declining Net Income and Recent Insider Sales
- CFO Cashes Out $580K in Equity, Reducing Direct Holdings
Financial Snapshot
Short Interest & Short Volume
14.36 days to coverFINRA reported short interest of 38,286 shares in KEQU as of the October 30, 2026 settlement, a 3.4% decrease from the prior period — about 14.4 days to cover at its recent average daily volume. On November 19, 2026, 44.4% of KEQU volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.